Medicare Program; Application by the American Association of Diabetes Educators (AADE) for Continued Recognition as a National Accreditation Organization for Accrediting Entities To Furnish Outpatient Diabetes Self-Management Training, 44255-44256 [2012-17293]
Download as PDF
Federal Register / Vol. 77, No. 145 / Friday, July 27, 2012 / Notices
VII. Files Available to the Public via the
Internet
This section lists the Addenda
referred to in the preamble of this
notice. Beginning in CY 2012, the
Addenda for the annual hospice wage
index proposed and final rulemakings
or notices will no longer appear in the
Federal Register. Instead, the Addenda
will be available only through the
Internet. We will continue to post the
Addenda through the Internet.
The following addenda are posted to
the CMS Web site at https://
www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/Hospice/
index.html:
Addendum A: The FY 2013 Hospice
Wage Index for Urban Areas
Addendum B: The FY 2013 Hospice
Wage Index for Rural Areas
Readers who experience any problems
accessing the Addenda that are posted
on the CMS Web site at https://
www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/Hospice/
index.html should contact Anjana Patel
at (410) 786–2120.
(Catalog of Federal Domestic Assistance
Program No. 93.778, No. 93.773 Medicare—
Hospital Insurance Program; and No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: June 5, 2012.
Marilyn Tavenner,
Acting Administrator, Centers for Medicare
& Medicaid Services.
Approved: July 16, 2012.
Kathleen Sebelius,
Secretary, Department of Health and Human
Services.
[FR Doc. 2012–18336 Filed 7–24–12; 4:15 pm]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
erowe on DSK2VPTVN1PROD with NOTICES
[CMS–3259–FN]
Medicare Program; Application by the
American Association of Diabetes
Educators (AADE) for Continued
Recognition as a National
Accreditation Organization for
Accrediting Entities To Furnish
Outpatient Diabetes Self-Management
Training
Centers for Medicare &
Medicare Services (CMS), HHS.
ACTION: Final Notice.
AGENCY:
This final notice announces
the approval of an application from the
SUMMARY:
VerDate Mar<15>2010
15:32 Jul 26, 2012
Jkt 226001
American Association of Diabetes
Educators for continued recognition as a
national accreditation program for
accrediting entities that wish to furnish
outpatient diabetes self-management
training to Medicare beneficiaries.
DATES: Effective Date: This notice is
effective on August 27, 2012.
FOR FURTHER INFORMATION CONTACT:
Jacqueline Leach, (410) 786–4282.
Kristin Shifflett, (410) 786–4133.
Maria Hammel, (410) 786–1775.
SUPPLEMENTARY INFORMATION
I. Background
Under the Medicare program, eligible
beneficiaries may receive outpatient
diabetes self-management training
(DSMT) when ordered by the physician
(or qualified non-physician practitioner)
treating the beneficiary’s diabetes,
provided certain requirements are met
by the provider. Pursuant to our
regulations at 42 CFR 410.141(e)(3), we
use national accrediting organizations
(NAOs) to assess whether provider
entities meet Medicare requirements
when providing DSMT services for
which Medicare payment is made. If a
provider entity is accredited by an
approved accrediting organization, it is
‘‘deemed’’ to meet applicable Medicare
requirements.
Under section 1865(a)(1)(B) of the
Social Security Act (the Act), a NAO
must have an agreement in effect with
the Secretary, and meet the standards
and requirements specified by the
Secretary in part 410, subpart H, to
qualify for deeming authority. The
regulations pertaining to application
procedures for NAOs for DSMT are
specified at § 410.142 (CMS process for
approving national accreditation
organizations).
A NAO applying for deeming
authority must provide us with
reasonable assurance that the
accrediting organization requires
accredited entities to meet requirements
that are at least as stringent as our
requirements.
We may approve and recognize a
nonprofit organization with
demonstrated experience in
representing the interests of individuals
with diabetes to accredit entities to
furnish DSMT. The accreditation
organization, after being approved and
recognized by CMS, may accredit an
entity to meet one of the sets of quality
standards in § 410.144 (Quality
standards for deemed entities).
Section 1865(a)(2) of the Act further
requires that we review the applying
accreditation organization’s
requirements for accreditation, as
follows:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
44255
• Survey procedures.
• Ability to provide adequate
resources for conducting required
surveys.
• Ability to supply information for
use in enforcement activities.
• Monitoring procedures for
providers found out of compliance with
the conditions or requirements.
• Ability to provide CMS with
necessary data for validation.
We then examine the NAO’s
accreditation requirements to determine
if they meet or exceed the Medicare
conditions as we would have applied
them. Section 1865(a)(3)(A) of the Act
requires that we publish a notice
identifying the national accreditation
body making the request within 30 days
of receipt of a completed application.
The notice must describe the nature of
the request and provide at least a 30-day
public comment period. We have 210
days from receipt of the request to
publish a finding of approval or denial
of the application. If we recognize an
accreditation organization in this
manner, any entity accredited by the
national accreditation body’s CMSapproved program for that service will
be ‘‘deemed’’ to meet the Medicare
conditions for coverage.
II. Provisions of the Proposed Notice
On February 24, 2012, we published
a proposed notice in the Federal
Register (77 FR 11130) entitled,
‘‘Application by the American
Association of Diabetes Educators
(AADE) for Continued Recognition as a
National Accreditation Organization for
Accrediting Entities to Furnish
Outpatient Diabetes Self-Management
Training,’’ to notify the public of the
AADE’s request for continued approval
of its accreditation to deem entities
furnishing DSMT services.
III. Analysis of and Responses to Public
Comments on the Proposed Notice
We received 1 public comment in
response to the February 24, 2012
proposed notice. A summary of the
comment and our response is set forth
below.
Comment: A commenter supported
the approval of the AADE to deem
DSMT programs. The commenter stated
that the AADE provides guidance for its
members and represents the values of
the profession. The commenter further
stated that qualified diabetes educators
can lead the way toward a healthier
population by guiding those with
chronic conditions toward healthier
lifestyles and stronger self-advocacy.
Response: We thank the commenter
for his or her comment. The goal of the
DSMT program is to provide
E:\FR\FM\27JYN1.SGM
27JYN1
44256
Federal Register / Vol. 77, No. 145 / Friday, July 27, 2012 / Notices
beneficiaries with tools to better manage
their diabetes and to achieve good
clinical and behavioral outcomes. Based
on the information submitted by the
AADE, we believe that the AADE is
striving to meet the same goals we
developed for quality DSMT.
IV. Provisions of the Final Notice
AADE’s application to continue as an
accredited NAO to deem entities for the
purposes of DSMT is approved for a
period of 3 years. The accreditation is
effective on August 27, 2012. This
approval is subject to renewal
subsequent to the receipt of an
application from the AADE and subject
to review, evaluation, and approval of
its program.
V. Collection of Information
Requirements
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995.
(Catalog of Federal Domestic Assistance
Program No. 93.773 Medicare-Hospital
Insurance Program; and No. 93.774,
Medicare-Supplementary Medical Insurance
Program)
Dated: July 3, 2012.
Marilyn Tavenner,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2012–17293 Filed 7–26–12; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–D–0630]
Draft Guidance for Industry and Food
and Drug Administration Staff; Safety
Considerations for 510(k) Submissions
To Mitigate the Risks of
Misconnections With Small-Bore
Connectors Intended for Enteral
Applications; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of the draft guidance
entitled ‘‘Safety Considerations for
510(k) Submissions to Mitigate the Risks
of Misconnections with Small-bore
Connectors Intended for Enteral
Applications.’’ The use of common
connector designs, such as luer
erowe on DSK2VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:32 Jul 26, 2012
Jkt 226001
connectors, has led to unintended
connections between devices that have
different intended uses and has resulted
in serious and sometimes fatal
consequences to patients. This guidance
provides recommendations to 510(k)
submitters regarding the submission
expectations regarding design and
testing to reduce the risk of unintended
connections between enteral and
nonenteral devices. This draft guidance
is not final nor is it in effect at this time.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
on the draft guidance by October 25,
2012.
ADDRESSES: Submit written requests for
single copies of the draft guidance
document entitled ‘‘Safety
Considerations for 510(k) Submissions
To Mitigate the Risks of Misconnections
With Small-Bore Connectors Intended
for Enteral Applications’’ to the Division
of Small Manufacturers, International,
and Consumer Assistance, Center for
Devices and Radiological Health, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 66, rm. 4613,
Silver Spring, MD 20993–0002. Send
one self-addressed adhesive label to
assist that office in processing your
request, or fax your request to 301–847–
8149. See the SUPPLEMENTARY
INFORMATION section for information on
electronic access to the guidance.
Submit electronic comments on the
draft guidance to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Identify
comments with the docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Priya Venkataraman-Rao, Center for
Devices and Radiological Health, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 66, rm. G222,
Silver Spring, MD 20993–0002, 301–
796–6243.
regarding luer lock misconnections.
FDA advised manufacturers to assess
the risks of misconnections for their
devices and provide proposed solutions
with validation for premarket review. At
that time, some manufacturers were
using color coding and labeling to
reduce the risk of misconnections;
others were creating proprietary
connectors designed to be incompatible
with nonenteral devices. However,
recent reports of adverse events have
demonstrated that reliance on colorcoding of enteral devices alone cannot
adequately mitigate the risk of
misconnections, especially with
similarly color-coded PICC
(percutaneously inserted central
catheter) lines on the market.
This guidance provides updated
recommendations to manufacturers on
the submission requirements for 510(k)s
for small-bore connectors used in
enteral applications. The guidance
recommends that 510(k) submitters (1)
Design and test enteral connectors based
on the Association for the Advancement
of Medical Instrumentation (AAMI)/
American National Standards Institute
(ANSI)/International Organization for
Standardization (ISO) 80369–1, ‘‘SmallBore Connectors for Liquids and Gases
in Healthcare Applications—Part 1:
General Requirements’’ standard; (2) no
longer rely strictly on color coding and
tagging to prevent misconnections; and
(3) perform risk assessments to
demonstrate that the proposed design
and testing has effectively mitigated the
risk of the proposed enteral connector
misconnecting to nonenteral devices.
I. Background
Multiple publications regarding
patient injury and death from tubing
and catheter misconnections indicate
that reports of misconnections have
gradually increased in frequency. On
July 9, 2010, FDA issued a letter to
health care professionals, hospital
purchasing departments, and
manufacturers of enteral feeding tubes
III. Electronic Access
Persons interested in obtaining a copy
of the draft guidance may do so by using
the Internet. A search capability for all
CDRH guidance documents is available
at https://www.fda.gov/MedicalDevices/
DeviceRegulationandGuidance/
GuidanceDocuments/default.htm.
Guidance documents are also available
at https://www.regulations.gov. To
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
II. Significance of Guidance
This draft guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the Agency’s current thinking
on mitigating the risks of
misconnections with small-bore
connectors intended for enteral
applications. It does not create or confer
any rights for or on any person and does
not operate to bind FDA or the public.
An alternative approach may be used if
such approach satisfies the
requirements of the applicable statute
and regulations.
E:\FR\FM\27JYN1.SGM
27JYN1
Agencies
[Federal Register Volume 77, Number 145 (Friday, July 27, 2012)]
[Notices]
[Pages 44255-44256]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17293]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3259-FN]
Medicare Program; Application by the American Association of
Diabetes Educators (AADE) for Continued Recognition as a National
Accreditation Organization for Accrediting Entities To Furnish
Outpatient Diabetes Self-Management Training
AGENCY: Centers for Medicare & Medicare Services (CMS), HHS.
ACTION: Final Notice.
-----------------------------------------------------------------------
SUMMARY: This final notice announces the approval of an application
from the American Association of Diabetes Educators for continued
recognition as a national accreditation program for accrediting
entities that wish to furnish outpatient diabetes self-management
training to Medicare beneficiaries.
DATES: Effective Date: This notice is effective on August 27, 2012.
FOR FURTHER INFORMATION CONTACT: Jacqueline Leach, (410) 786-4282.
Kristin Shifflett, (410) 786-4133.
Maria Hammel, (410) 786-1775.
SUPPLEMENTARY INFORMATION
I. Background
Under the Medicare program, eligible beneficiaries may receive
outpatient diabetes self-management training (DSMT) when ordered by the
physician (or qualified non-physician practitioner) treating the
beneficiary's diabetes, provided certain requirements are met by the
provider. Pursuant to our regulations at 42 CFR 410.141(e)(3), we use
national accrediting organizations (NAOs) to assess whether provider
entities meet Medicare requirements when providing DSMT services for
which Medicare payment is made. If a provider entity is accredited by
an approved accrediting organization, it is ``deemed'' to meet
applicable Medicare requirements.
Under section 1865(a)(1)(B) of the Social Security Act (the Act), a
NAO must have an agreement in effect with the Secretary, and meet the
standards and requirements specified by the Secretary in part 410,
subpart H, to qualify for deeming authority. The regulations pertaining
to application procedures for NAOs for DSMT are specified at Sec.
410.142 (CMS process for approving national accreditation
organizations).
A NAO applying for deeming authority must provide us with
reasonable assurance that the accrediting organization requires
accredited entities to meet requirements that are at least as stringent
as our requirements.
We may approve and recognize a nonprofit organization with
demonstrated experience in representing the interests of individuals
with diabetes to accredit entities to furnish DSMT. The accreditation
organization, after being approved and recognized by CMS, may accredit
an entity to meet one of the sets of quality standards in Sec. 410.144
(Quality standards for deemed entities).
Section 1865(a)(2) of the Act further requires that we review the
applying accreditation organization's requirements for accreditation,
as follows:
Survey procedures.
Ability to provide adequate resources for conducting
required surveys.
Ability to supply information for use in enforcement
activities.
Monitoring procedures for providers found out of
compliance with the conditions or requirements.
Ability to provide CMS with necessary data for validation.
We then examine the NAO's accreditation requirements to determine
if they meet or exceed the Medicare conditions as we would have applied
them. Section 1865(a)(3)(A) of the Act requires that we publish a
notice identifying the national accreditation body making the request
within 30 days of receipt of a completed application. The notice must
describe the nature of the request and provide at least a 30-day public
comment period. We have 210 days from receipt of the request to publish
a finding of approval or denial of the application. If we recognize an
accreditation organization in this manner, any entity accredited by the
national accreditation body's CMS-approved program for that service
will be ``deemed'' to meet the Medicare conditions for coverage.
II. Provisions of the Proposed Notice
On February 24, 2012, we published a proposed notice in the Federal
Register (77 FR 11130) entitled, ``Application by the American
Association of Diabetes Educators (AADE) for Continued Recognition as a
National Accreditation Organization for Accrediting Entities to Furnish
Outpatient Diabetes Self-Management Training,'' to notify the public of
the AADE's request for continued approval of its accreditation to deem
entities furnishing DSMT services.
III. Analysis of and Responses to Public Comments on the Proposed
Notice
We received 1 public comment in response to the February 24, 2012
proposed notice. A summary of the comment and our response is set forth
below.
Comment: A commenter supported the approval of the AADE to deem
DSMT programs. The commenter stated that the AADE provides guidance for
its members and represents the values of the profession. The commenter
further stated that qualified diabetes educators can lead the way
toward a healthier population by guiding those with chronic conditions
toward healthier lifestyles and stronger self-advocacy.
Response: We thank the commenter for his or her comment. The goal
of the DSMT program is to provide
[[Page 44256]]
beneficiaries with tools to better manage their diabetes and to achieve
good clinical and behavioral outcomes. Based on the information
submitted by the AADE, we believe that the AADE is striving to meet the
same goals we developed for quality DSMT.
IV. Provisions of the Final Notice
AADE's application to continue as an accredited NAO to deem
entities for the purposes of DSMT is approved for a period of 3 years.
The accreditation is effective on August 27, 2012. This approval is
subject to renewal subsequent to the receipt of an application from the
AADE and subject to review, evaluation, and approval of its program.
V. Collection of Information Requirements
This document does not impose information collection and
recordkeeping requirements. Consequently, it need not be reviewed by
the Office of Management and Budget under the authority of the
Paperwork Reduction Act of 1995.
(Catalog of Federal Domestic Assistance Program No. 93.773 Medicare-
Hospital Insurance Program; and No. 93.774, Medicare-Supplementary
Medical Insurance Program)
Dated: July 3, 2012.
Marilyn Tavenner,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2012-17293 Filed 7-26-12; 8:45 am]
BILLING CODE 4120-01-P